OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Update Breast Cancer 2021 Part 3 – Current Developments in the Treatment of Early Breast Cancer: Review and Assessment of Specialised Treatment Scenarios by an International Expert Panel
Tanja Fehm, Elmar Stickeler, Peter A. Fasching, et al.
Geburtshilfe und Frauenheilkunde (2021) Vol. 81, Iss. 06, pp. 654-665
Open Access | Times Cited: 5
Tanja Fehm, Elmar Stickeler, Peter A. Fasching, et al.
Geburtshilfe und Frauenheilkunde (2021) Vol. 81, Iss. 06, pp. 654-665
Open Access | Times Cited: 5
Showing 5 citing articles:
Endocrine Treatment for Breast Cancer Patients Revisited—History, Standard of Care, and Possibilities of Improvement
Naiba Nabieva, Peter A. Fasching
Cancers (2021) Vol. 13, Iss. 22, pp. 5643-5643
Open Access | Times Cited: 27
Naiba Nabieva, Peter A. Fasching
Cancers (2021) Vol. 13, Iss. 22, pp. 5643-5643
Open Access | Times Cited: 27
Investigation of Molecular Mechanisms Involved in Sensitivity to the Anti-Cancer Activity of Costunolide in Breast Cancer Cells
Yu‐Jeong Choi, Youn Kyung Choi, Seong‐Gyu Ko, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4009-4009
Open Access | Times Cited: 10
Yu‐Jeong Choi, Youn Kyung Choi, Seong‐Gyu Ko, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4009-4009
Open Access | Times Cited: 10
BRCA1, BCL2, and the RB Tumor Suppressor have abnormal expressions in lung cancer
Marwa Mohammed Ali Jassim, Shaymaa A. Naji, Majid Mohammed Mahmood
Research Journal of Pharmacy and Technology (2022), pp. 4083-4087
Closed Access | Times Cited: 2
Marwa Mohammed Ali Jassim, Shaymaa A. Naji, Majid Mohammed Mahmood
Research Journal of Pharmacy and Technology (2022), pp. 4083-4087
Closed Access | Times Cited: 2
Is the (Neo)adjuvant Therapy of Patients with Primary HER2-positive Breast Cancer Cost-Covering?
Natalia Krawczyk, Eugen Ruckhäberle, Michael P. Lux, et al.
Geburtshilfe und Frauenheilkunde (2022) Vol. 83, Iss. 03, pp. 321-332
Open Access | Times Cited: 1
Natalia Krawczyk, Eugen Ruckhäberle, Michael P. Lux, et al.
Geburtshilfe und Frauenheilkunde (2022) Vol. 83, Iss. 03, pp. 321-332
Open Access | Times Cited: 1
Differential Expression of lincRNA-ROR Spliced Transcript Variants in Breast Cancer
Mozhgan Saadat Akhtar, Akram Gholipour, Mahrokh Bagheri Moghaddam, et al.
Iranian Journal of Public Health (2023)
Open Access
Mozhgan Saadat Akhtar, Akram Gholipour, Mahrokh Bagheri Moghaddam, et al.
Iranian Journal of Public Health (2023)
Open Access
